Phospholamban: a promising therapeutic target in heart failure?

AG Schmidt, I Edes, EG Kranias - Cardiovascular drugs and therapy, 2001 - Springer
… Dilated cardiomyopathy and end-stage heart failure result in characteristic functional, …
protein, phospholamban, as potential therapeutic targets. We summarize structural and genetic …

[HTML][HTML] The Elabela-APJ axis: a promising therapeutic target for heart failure

Z Ma, JJ Song, S Martin, XC Yang, JC Zhong - Heart Failure Reviews, 2021 - Springer
Heart failure (HF) is a growing epidemic with high morbidity and mortality at an international
… been implicated in HF, making it a promising therapeutic target. APJ has been shown to be …

AMPK activation, a preventive therapeutic target in the transition from cardiac injury to heart failure

C Beauloye, L Bertrand, S Horman… - Cardiovascular …, 2011 - academic.oup.com
… as a potential therapeutic target. … or therapeutic effects in the energy-deprived failing heart.
In this chapter, we summarize the current knowledge on the energetic state of the failing heart, …

New therapeutic targets in cardiology: heart failure and arrhythmia: HCN channels

F Roubille, JC Tardif - Circulation, 2013 - Am Heart Assoc
… of cardiovascular death or hospitalization for worsening of heart failure (A), on hospitalization
for worsening of heart failure (B), on death from heart failure (C), and on cardiovascular …

Caspase-3 as a therapeutic target for heart failure

B Yang, D Ye, Y Wang - Expert opinion on therapeutic targets, 2013 - Taylor & Francis
therapy has emerged as an enigma for heart failure. Caspases promote the progressive loss
of contractile function in heart failure by … Therapeutic targets for heart failure: beyond beta-…

Role of inflammation in the pathogenesis of heart failure with preserved ejection fraction and its potential as a therapeutic target

N Glezeva, JA Baugh - Heart failure reviews, 2014 - Springer
Heart failure (HF) with preserved ejection fraction (HFPEF) is an increasingly prevalent
clinical syndrome with many unresolved issues regarding diagnosis, pathophysiology, and …

[HTML][HTML] Angiotensin-converting enzyme 2 as a therapeutic target for heart failure

MAR Chamsi-Pasha, Z Shao, WHW Tang - Current heart failure reports, 2014 - Springer
… ACE2-Ang(1–7) axis with regards to clinical implications and therapeutic targets in cardiovascular
disorders, with emphasis on the potential therapeutic role in cardiovascular diseases. …

Therapeutic targets for heart failure identified using proteomics and Mendelian randomization

A Henry, M Gordillo-Marañón, C Finan, AF Schmidt… - Circulation, 2022 - Am Heart Assoc
… -MR analyses of circulating protein levels for therapeutic target identification and prioritization
in HF, … the druggability properties of these proteins as potential therapeutic targets for HF. …

The PGC-1 cascade as a therapeutic target for heart failure

J Schilling, DP Kelly - Journal of molecular and cellular cardiology, 2011 - Elsevier
… disturbances that presage heart failure due to common … therapeutic target for novel
therapeutics aimed at reversing the energy metabolic disturbances that contribute to heart failure. …

Heart rate: a prognostic factor and therapeutic target in chronic heart failure. The distinct roles of drugs with heart rate‐lowering properties

D Dobre, JS Borer, K Fox, K Swedberg… - … of heart failure, 2014 - Wiley Online Library
Heart rate not only predicts outcome but may also be a therapeutic target in patients with
chronic heart failure… Several classes of pharmacological agents can be used to modulate heart